Opioid dependence during pregnancy: Relationships of anxiety and depression symptoms to treatment outcomes

Addiction

Volumn 107, Issue SUPPL.1, 2012, Pages 74-82

  Benningfield, Margaret M ^a   Dietrich, Mary S ^a   Jones, Hendrée E ^b,c   Kaltenbach, Karol ^d   Heil, Sarah H ^e   Stine, Susan M ^f   Coyle, Mara G ^g   Arria, Amelia M ^h   O'Grady, Kevin E ⁱ   Fischer, Gabriele ^j   Martin, Peter R ^a  

^a VANDERBILT UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c RTI INTERNATIONAL   (United States)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

^e UNIVERSITY OF VERMONT   (United States)

^f WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g BROWN UNIVERSITY   (United States)

^h UNIVERSITY OF MARYLAND   (United States)

ⁱ UNIVERSITY OF MARYLAND   (United States)

^j MEDICAL UNIVERSITY OF VIENNA   (Austria)

more..

Author keywords

Anxiety; Buprenorphine; Depression; Methadone; Opioid dependence; Outcomes; Pregnancy; Treatment retention

Indexed keywords

BUPRENORPHINE; METHADONE; NARCOTIC ANALGESIC AGENT;

ADOLESCENT; ADULT; ANXIETY; ARTICLE; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MULTICENTER STUDY; OPIATE ADDICTION; OPIATE SUBSTITUTION TREATMENT; PATIENT COMPLIANCE; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PSYCHOLOGIC TEST; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL; STATISTICS; TREATMENT OUTCOME; URINE;

ADOLESCENT; ADULT; ANALGESICS, OPIOID; ANXIETY; BUPRENORPHINE; COMORBIDITY; DEPRESSION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INTERVIEW, PSYCHOLOGICAL; LOGISTIC MODELS; METHADONE; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PATIENT COMPLIANCE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84868104576     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2012.04041.x     Document Type: Article

References (18)

1. Jones H. E., Kaltenbach K., Heil S. H., Stine S. M., Coyle M. G., Arria A. M. etal. Neonatal abstinence syndrome after methadone or buprenorphine exposure. N Engl J Med 2010; 363: 2320-2331.
2. Jones H. E., Martin P. R., Heil S. H., Kaltenbach K., Selby P., Coyle M. G. etal. Treatment of opioid-dependent pregnant women: clinical and research issues. J Subst Abuse Treat 2008; 35: 245-259.
3. Benningfield M. M., Arria A. M., Kaltenbach K., Heil S. H., Stine S. M., Coyle M. G. etal. Co-occurring psychiatric symptoms are associated with increased psychological, social, and medical impairment in opioid dependent pregnant women. Am J Addict 2010; 19: 416-421.
4. Fitzsimons H. E., Tuten M., Vaidya V., Jones H. E. Mood disorders affect drug treatment success of drug-dependent pregnant women. J Subst Abuse Treat 2007; 32: 19-25.
5. Kessler R. C., Mcgonagle K. A., Zhao S. Y., Nelson C. B., Hughes M., Eshleman S. etal. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States-results from the National Comorbidity Survey. Arch Gen Psychiatry 1994; 51: 8-19.
6. Bennett H. A., Einarson A., Taddio A., Koren G., Einarson T. R. Prevalence of depression during pregnancy: systematic review. Obstet Gynecol 2004; 103: 698-709.
7. Curran G. M., Kirchner J. E., Worley M., Rookey C., Booth B. M. Depressive symptomatology and early attrition from intensive outpatient substance use treatment. J Behav Health Serv Res 2002; 29: 138-143.
8. Kleinman P. H., Kang S. Y., Lipton D. S., Woody G. E., Kemp J., Millman R. B. Retention of cocaine abusers in outpatient psychotherapy. Am J Drug Alcohol Abuse 1992; 18: 29-43.
9. Gerra G., Leonardi C., D'Amore A., Strepparola G., Fagetti R., Assi C. etal. Buprenorphine treatment outcome in dually diagnosed heroin dependent patients: a retrospective study. Prog Neuropsychopharmacol Biol Psychiatry 2006; 30: 265-272.
10. Alegria A. A., Hasin D. S., Nunes E. V., Liu S. M., Davies C., Grant B. F. etal. Comorbidity of generalized anxiety disorder and substance use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry 2010; 71: 1187-1195.
11. Tuten M., Heil S. H., O'Grady K. E., Fitzsimons H., Chisolm M. S., Jones H. E. The impact of mood disorders on the delivery and neonatal outcomes of methadone-maintained pregnant patients. Am J Drug Alcohol Abuse 2009; 35: 358-363.
12. Jones H. E., Fischer G., Heil S. H., Kaltenbach K., Martin P. R., Coyle M. G. etal. Maternal Opioid Treatment: Human Experimental Research (MOTHER)-approach, issues, and lessons learned. Addiction 2012; 107 (Suppl. 1): 28-35.
13. Martin P. R., Arria A. M., Fischer G., Kaltenbach K., Heil S. H., Stine S. M. etal. Psychopharmacologic management of opioid-dependent women during pregnancy. Am J Addict 2009; 18: 148-156.
14. First M. B., Spitzer R. L., Gibbon M., Williams J. B. W. Structured clinical interview for DSM-IV Axis I disorders. New York: Biometrics Research, New York State Psychiatric Institution; 1996.
15. Sheehan D. V., Lecrubier Y., Sheehan K. H., Amorim P., Janavs J., Weiller E. etal. The Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998; 59: 22-33.
16. Hides L., Lubman D. I., Devlin H., Cotton S., Aitken C., Gibbie T. etal. Reliability and validity of the Kessler 10 and Patient Health Questionnaire among injecting drug users. Aust NZ J Psychiatry 2007; 41: 166-168.
17. Chiang S. C., Chan H. Y., Chang Y. Y., Sun H. J., Chen W. J., Chen C. K. Psychiatric comorbidity and gender difference among treatment-seeking heroin abusers in Taiwan. Psychiatry Clin Neurosci 2007; 61: 105-111.
18. McLellan A. T., Kushner H., Metzger D., Peters R., Smith I., Grissom G. etal. The Fifth Edition of the Addiction Severity Index. J Subst Abuse Treat 1992; 9: 199-213.